Marina Biotech, Inc. (MRNA) Reports Q3 Loss of $0.05

Marina Biotech, Inc. (NASDAQ: MRNA) reported Q3 EPS of ($0.05), versus ($0.39) reported last year. Revenue for the quarter came in at $286 thousand, versus $1.13 million reported last year.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Moderna (MRNA) call put ratio 3.5 calls to 1 put with a focus on July 72 and 77 calls as share price down 9.5%
• Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
• JPMorgan analysts name top short ideas for third quarter 2026